✦ LIBER ✦

The Immunosuppressant Drug FTY720 Inhibits Cytosolic Phospholipase A2 Independently of Sphingosine-1-Phosphate Receptors

✍ Scribed by Spiegel, S.; Payne, S.; Oskeritzian, C.; Milstien, S.

Book ID: 122866681
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 48 KB
Volume: 119
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2006.12.597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The immunosuppressant FTY720 inhibits tu

The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1

✍ Gerald Schmid; Markus Guba; Ivan Ischenko; Armine Papyan; Mareile Joka; Sabine S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract FTY720, a sphingosine 1‐phosphate (S1P) analog, acts as an immunosuppressant through trapping of T cells in secondary lymphoid tissues. FTY720 was also shown to prevent tumor growth and to inhibit vascular permeability. The MTT proliferation assay illustrated that endothelial cells are

(S)-FTY720-Vinylphosphonate, an analogue

(S)-FTY720-Vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity

✍ William J. Valentine; Gyöngyi N. Kiss; Jianxiong Liu; Shuyu E; Mari Gotoh; Kimik 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 776 KB

The enhancement of bone allograft incorp

The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720

✍ Caren E. Petrie Aronin; Soo J. Shin; Kimberly B. Naden; Peter D. Rios Jr.; Laure 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 951 KB

Poor vascularization coupled with mechanical instability is the leading cause of post-operative complications and poor functional prognosis of massive bone allografts. To address this limitation, we designed a novel continuous polymer coating system to provide sustained localized delivery of pharmac

The Sphingosine-1-phosphate Receptor Mod

The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes With 5-FU to Inhibit Growth of Human Colon Cancer Cells

✍ Aoyagi, T.; Yamada, A.; Nagahashi, M.; Adams, B.J.; Milstien, S.; Spiegel, S.; T 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

The Preclinical Development of FTY720, A

The Preclinical Development of FTY720, A Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy Against Breast Cancer

✍ B.J. Adams; M. Nagahashi; S. Ramachandran; N.C. Hait; S. Milstien; S. Spiegel; K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

FTY720, a new class of immunomodulator,

FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors

✍ Kenji Chiba 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 406 KB